|
2024
|
Invention
|
Anti-npr1 antibody and pharmaceutical use thereof. Provided are an anti-NPR1 antibody, a pharmace... |
|
|
Invention
|
Amorphous substance and crystal of dioxopiperidine compound or pharmaceutically acceptable salt t... |
|
|
Invention
|
Anti-tf antibody and anti-tf antibody-drug conjugate and medical use thereof. The present inventi... |
|
|
Invention
|
Antigen binding molecule specifically binding to egfr and muc1, drug conjugate thereof, and medic... |
|
|
Invention
|
Fused tetracyclic compound and preparation method therefor and use thereof in medicine. The prese... |
|
|
Invention
|
Conjugate of anti-ror1 antibody and pbd compound, and preparation method therefor and use thereof... |
|
|
Invention
|
Anti-dll3 antibody, and antibody-drug conjugate and pharmaceutical use thereof. Provided are an a... |
|
|
Invention
|
Crystalline form of sulfonamide derivative and preparation method therefor. The present disclosur... |
|
|
Invention
|
Pharmaceutical composition containing eribulin derivative drug conjugate. The present disclosure ... |
|
|
Invention
|
Substituted aminopyrimidine macrocyclic compounds, preparation method therefor, and medical uses ... |
|
2023
|
Invention
|
Crystal form of kras g12d inhibitor and preparation method therefor. The present disclosure relat... |
|
|
Invention
|
Anti-her3 antibody-drug conjugate composition and pharmaceutical use thereof. The present inventi... |
|
|
Invention
|
Pharmaceutically acceptable salt of quinoline amine compound, and crystal form thereof and prepar... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding to hgfr and egfr. ... |
|
|
Invention
|
Quinoline amine compound crystal form and preparation method therefor. The present disclosure rel... |
|
|
Invention
|
Pharmaceutically acceptable salt of nitrogen-containing heterocyclic compound, crystal form there... |
|
|
Invention
|
Use of combination of anti-pd-1 antibody and vegfr inhibitor in preparation of drug for treating ... |
|
|
Invention
|
Crystalline form of pharmaceutically acceptable salt of pyrazolo heteroaryl derivative. The prese... |
|
|
Invention
|
Fused tricyclic compound, preparation method therefor, and pharmaceutical use thereof. The presen... |
|
|
Invention
|
Pharmaceutical composition comprising anti-rankl-ngf bispecific antibodies. The present disclosur... |
|
|
Invention
|
Substituted aminopyrimidine compound, preparation method therefor, and medical use thereof. A sub... |
|
|
Invention
|
Pharmaceutical composition containing isoquinolinone compound, and preparation method therefor. T... |
|
|
Invention
|
Chimeric compound used for targeted degradation of bcl-2 protein, preparation method therefor, an... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystal form of tetrahydronaphthalene derivative, and prepar... |
|
|
Invention
|
Anti-ilt4 antibody and pharmaceutical use thereof. The present invention provides an anti-ILT4 an... |
|
|
Invention
|
Heterocyclic compound, preparation method therefor, and pharmaceutical use thereof. The present i... |
|
|
Invention
|
Fused bicyclic compound, and preparation method therefor and use thereof in medicine. The present... |
|
|
Invention
|
Fused tricyclic compound, preparation method therefor, and medical use thereof. The present discl... |
|
|
Invention
|
Heterocyclic compound, method for preparing same, and pharmaceutical use thereof. The present dis... |
|
|
Invention
|
Antigen-binding molecule specifically binding to gucy2c and cd3 and pharmaceutical use thereof. P... |
|
|
Invention
|
Pharmaceutical composition comprising kras g12d inhibitor. The present disclosure relates to a ph... |
|
|
Invention
|
Fused ring compound, preparation method therefor and medicinal application thereof. The present d... |
|
2022
|
Invention
|
Anti-sost antibody pharmaceutical composition and use thereof.
The present invention relates to ... |
|
|
Invention
|
Anti-il23 antibody fusion protein and uses thereof.
An anti-IL23 antibody fusion protein and use... |
|
|
Invention
|
Anti-klb antibodies and uses.
The present disclosure relates to anti-KLB antibodies and uses. |
|
|
Invention
|
Drug conjugate of eribulin derivative.
A drug conjugate of an Eribulin derivative. Specifically,... |
|
|
Invention
|
Pharmaceutical composition of anti-angptl3 antibody or antigen binding fragment thereof and its a... |
|
|
Invention
|
Pharmaceutical composition containing anti-trop2 antibody drug conjugate and its application.
Th... |
|
|
Invention
|
Antigen-binding molecule specifically binding to hgfr and egfr, and pharmaceutical use thereof.
... |
|
|
Invention
|
Salt types of tricyclic tetrahydro isoquinoline derivative.
The present disclosure relates to sa... |
|
|
Invention
|
Fused tetracyclic compound, preparation method therefor and application thereof in medicine.
The... |
|
|
Invention
|
Quinolinamine compound, preparation method therefor and application thereof in pharmaceuticals.
... |
|
|
Invention
|
Nitrogen-containing heterocyclic compound, preparation method therefor, and application thereof i... |
|
|
Invention
|
Pharmaceutically acceptable salt of pyrazoloheteroaryl derivative and crystal form thereof.
The ... |
|
|
Invention
|
Antigen-binding molecule.
Provided is an antigen-binding molecule, particularly a domain-enginee... |
|
|
Invention
|
Antigen binding molecule specifically binding to rankl and ngf, and medical use thereof.
The pre... |
|
|
Invention
|
Anti-nectin-4 antibody and anti-nectin-4 antibody-drug conjugate, and medicinal use thereof.
Pro... |
|
|
Invention
|
Truncated taci polypeptide and fusion protein and use thereof.
The present application relates t... |
|
2021
|
Invention
|
Fused tricyclic compound, preparation method therefor and application thereof in medicine.
The p... |
|
2019
|
Invention
|
Cd40 antibody pharmaceutical composition and use thereof.
The present invention provides a pharm... |
